ABSCI CORP(NASDAQ:ABSI) stock News

ABSI Latest News, Press Relases and Analysis

All

Press Releases

7 days ago - By: Absci Corporation

Absci to Host KOL Seminar on ABS-201 Androgenetic Alopecia Program on December 11, 2025; Announces Accelerated Initiation of Phase 1/2a Trial

7 days ago - By: Absci Corporation

Absci to Host KOL Seminar on ABS-201 Androgenetic Alopecia Program on December 11, 2025; Announces Accelerated Initiation of Phase 1/2a Trial

14 days ago - By: Benzinga - Mentions: GSRT DGNX PLG CENX ...

Dell, Select Medical, Century Aluminum And Other Big Stocks Moving Higher On Wednesday

20 days ago - By: Benzinga - Mentions: SNPS CRSR CNTX TBCH

This Synopsys Analyst Begins Coverage On A Bearish Note; Here Are Top 5 Initiations For Thursday

a month ago - By: Absci Corporation; Oracle; AMD

Absci Accelerates AI-Driven Drug Discovery with Oracle and AMD

a month ago - By: Absci Corporation; Oracle; AMD - Mentions: AMD ORCL

Absci Accelerates AI-Driven Drug Discovery with Oracle and AMD

2 months ago - By: Absci Corporation

Absci Expands ABS-201 Scientific Advisory Board with Addition of Leading Dermatology Experts Dr. Rodney Sinclair and Dr. David Goldberg

2 months ago - By: Absci Corporation

Absci Expands ABS-201 Scientific Advisory Board with Addition of Leading Dermatology Experts Dr. Rodney Sinclair and Dr. David Goldberg

2 months ago - By: Absci Corporation

Absci to Participate in Upcoming Investor Conferences

2 months ago - By: Absci Corporation

Absci to Participate in Upcoming Investor Conferences

2 months ago - By: The Motley Fool

Absci Sales Fall 54 Percent

2 months ago - By: Zacks Investment Research - Mentions: CLNN

Absci Corporation (ABSI) Reports Q2 Loss, Misses Revenue Estimates

2 months ago - By: Absci Corporation

Absci Reports Business Updates and Second Quarter 2025 Financial and Operating Results

2 months ago - By: Absci Corporation

Absci Reports Business Updates and Second Quarter 2025 Financial and Operating Results

3 months ago - By: Zacks Investment Research - Mentions: SABS

SAB Biotherapeutics, Inc. (SABS) Expected to Beat Earnings Estimates: What to Know Ahead of Q2 Release

3 months ago - By: Absci Corporation

Almirall and Absci Expand AI Drug Creation Collaboration Adding a Second Dermatology Target

3 months ago - By: Absci Corporation

Almirall and Absci Expand AI Drug Creation Collaboration Adding a Second Dermatology Target

3 months ago - By: Zacks Investment Research - Mentions: AMGN

Amgen (AMGN) Beats Q2 Earnings and Revenue Estimates

3 months ago - By: Zacks Investment Research - Mentions: SNDX

Syndax Pharmaceuticals (SNDX) Reports Q2 Loss, Beats Revenue Estimates

3 months ago - By: Absci Corporation

Absci to Report Business Updates and Second Quarter 2025 Financial and Operating Results on August 12, 2025

3 months ago - By: Absci Corporation

Absci to Report Business Updates and Second Quarter 2025 Financial and Operating Results on August 12, 2025

3 months ago - By: Absci Corporation

ABSCI CORP (ABSI) Stock News

ABSI Latest News, Press Relases and Analysis

Absci to Host KOL Seminar on ABS-201 Androgenetic Alopecia Program on December 11, 2025; Announces Accelerated Initiation of Phase 1/2a Trial

Absci to Host KOL Seminar on ABS-201 Androgenetic Alopecia Program on December 11, 2025; Announces Accelerated Initiation of Phase 1/2a Trial

Dell, Select Medical, Century Aluminum And Other Big Stocks Moving Higher On Wednesday

This Synopsys Analyst Begins Coverage On A Bearish Note; Here Are Top 5 Initiations For Thursday

Absci Accelerates AI-Driven Drug Discovery with Oracle and AMD

Absci Accelerates AI-Driven Drug Discovery with Oracle and AMD

Absci Expands ABS-201 Scientific Advisory Board with Addition of Leading Dermatology Experts Dr. Rodney Sinclair and Dr. David Goldberg

Absci Expands ABS-201 Scientific Advisory Board with Addition of Leading Dermatology Experts Dr. Rodney Sinclair and Dr. David Goldberg

Absci to Participate in Upcoming Investor Conferences

Absci to Participate in Upcoming Investor Conferences

Absci Sales Fall 54 Percent

Absci Corporation (ABSI) Reports Q2 Loss, Misses Revenue Estimates

Absci Reports Business Updates and Second Quarter 2025 Financial and Operating Results

Absci Reports Business Updates and Second Quarter 2025 Financial and Operating Results

SAB Biotherapeutics, Inc. (SABS) Expected to Beat Earnings Estimates: What to Know Ahead of Q2 Release

Almirall and Absci Expand AI Drug Creation Collaboration Adding a Second Dermatology Target

Almirall and Absci Expand AI Drug Creation Collaboration Adding a Second Dermatology Target

Amgen (AMGN) Beats Q2 Earnings and Revenue Estimates

Syndax Pharmaceuticals (SNDX) Reports Q2 Loss, Beats Revenue Estimates

Absci to Report Business Updates and Second Quarter 2025 Financial and Operating Results on August 12, 2025

Absci to Report Business Updates and Second Quarter 2025 Financial and Operating Results on August 12, 2025

Absci Announces Pricing of Public Offering of Common Stock